Trxade Group Inc (MEDS) - Total Liabilities

Latest as of June 2024: $3.06 Million USD

Based on the latest financial reports, Trxade Group Inc (MEDS) has total liabilities worth $3.06 Million USD as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Trxade Group Inc to measure how many days the company can operate on defensive assets alone.

Trxade Group Inc - Total Liabilities Trend (2006–2023)

This chart illustrates how Trxade Group Inc's total liabilities have evolved over time, based on quarterly financial data. Check MEDS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Trxade Group Inc Competitors by Total Liabilities

The table below lists competitors of Trxade Group Inc ranked by their total liabilities.

Company Country Total Liabilities
NCC Group plc
LSE:NCC
UK GBX136.80 Million
Landmarks Bhd
KLSE:1643
Malaysia RM376.30 Million
Labat Africa Ltd
JSE:LAB
South Africa ZAC456.03 Million
Throgmorton Trust Plc
LSE:THRG
UK GBX6.49 Million
Openlearning Ltd
AU:OLL
Australia AU$5.43 Million
333D Ltd
AU:T3D
Australia AU$385.73K
Princess Private Equity Holding Ltd
LSE:PEYS
UK GBX93.06 Million

Liability Composition Analysis (2006–2023)

This chart breaks down Trxade Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Trxade Group Inc assets under control.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.26 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Trxade Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Trxade Group Inc (2006–2023)

The table below shows the annual total liabilities of Trxade Group Inc from 2006 to 2023.

Year Total Liabilities Change
2023-12-31 $11.99 Million +256.10%
2022-12-31 $3.37 Million +68.70%
2021-12-31 $2.00 Million +79.25%
2020-12-31 $1.11 Million -22.20%
2019-12-31 $1.43 Million +3.50%
2018-12-31 $1.38 Million +48.80%
2017-12-31 $929.41K -37.42%
2016-12-31 $1.49 Million -15.65%
2015-12-31 $1.76 Million +217.99%
2014-12-31 $553.68K +102.81%
2013-12-31 $273.00K +169.78%
2012-12-31 $101.19K -99.79%
2008-12-31 $48.70 Million +239975.92%
2007-12-31 $20.28K +479.54%
2006-12-31 $3.50K --

About Trxade Group Inc

NASDAQ:MEDS USA Pharmaceutical Retailers
Market Cap
$5.04 Million
Market Cap Rank
#28592 Global
#5855 in USA
Share Price
$2.88
Change (1 day)
-6.19%
52-Week Range
$0.85 - $6.07
All Time High
$67.12
About

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.